To further elucidate the mechanisms by which UBE2S upregulation modulates HCC cell chemoresistance, we conducted GSEA upon the expression levels of UBE2S in TCGA-LIHC database. The gene discussed is UBE2S; the disease is hepatocellular carcinoma.